| 4-HNE | 4-hydroxynonenal |
| 5-HT | 5-hydroxytryptamine |
| Bcl-xL | B-cell lymphoma-extra large |
| BDNF | Brain derived neurotrophic factor |
| cKO | Conditional knockout |
| DMEM | Dulbecco’s Modified Eagle Medium |
| DR | Dorsal raphe |
| E# | Embryonic day |
| En1 | Engrailed 1 |
| ERK1/2 | Extracellular signal–regulated kinases-1/2 |
| GAPDH | Glyceraldehyde 3-phosphate dehydrogenase |
| H3 | Histone 3 |
| JNK1/2 | c-Jun N-terminal kinases |
| L-type Ca2+ | Long-lasting calcium channel |
| LUHMES | Lund Human Mesencephalic |
| MAPK | Mitogen-activated protein kinase |
| MEK | Mitogen-activated protein kinase kinase |
| mDA | Midbrain dopaminergic |
| MDA | Malondialdehyde |
| NCX3 | Na+/Ca2+ exchanger 3 |
| NGF | Nerve growth factor |
| PC12 | Pheochromocytoma of the rat adrenal medulla |
| PD | Parkinson’s disease |
| PINK1 | PTEN-induced kinase 1 or PTEN-induced putative kinase 1 |
| ROS | Reactive oxygen species |
| siRNA | Silencing RNA |
| SLC8A3 | Solute carrier Family 8 member A3 |
| Smad | Small mother against decapentaplegic |
| SNc | Substantia nigra pars compacta |
| TGF-β | Transforming growth factor beta |
| TRPC | Transient receptor potential canonical channels |
| TβRII | Type II TGF-β receptor |
| vH | Ventral hindbrain |
| VTA | Ventral tegmental area |
| Wt | Wildtype |